Manage Oncologic Emergencies With Multiple Myeloma

As new therapies come to market, patients with multiple myeloma (MM) have more treatment options that are improving outcomes and extending overall survival. However, the most effective options involve multidrug combinations and continuous maintenance therapy, which can result in cumulative toxicities and the potential for oncologic emergencies (OEs).

The Clinical Journal of Oncology Nursing published a supplement to its October 2017 issue that discussed treatment and symptom management options for patients with MM, including an overview of evidence-based recommendations for key OEs: myelosuppression, bone disease, and acute renal failure.